Genetic Variation in GIPR Influences the Glucose and Insulin Responses to an Oral Glucose Challenge

Glucose levels 2 h after an oral glucose challenge are a clinical measure of glucose tolerance used in the diagnosis of type 2 diabetes. We report a meta-analysis of nine genome-wide association studies (n = 15,234 nondiabetic individuals) and a follow-up of 29 independent loci (n = 6,958-30,620). We identify variants at the GIPR locus associated with 2-h glucose level (rs10423928, beta (s.e.m.) = 0.09 (0.01) mmol/l per A allele, P = 2.0 x 10(-15)). The GIPR A-allele carriers also showed decreased insulin secretion (n = 22,492; insulinogenic index, P = 1.0 x 10(-17); ratio of insulin to glucose area under the curve, P = 1.3 x 10(-16)) and diminished incretin effect (n = 804; P = 4.3 x 10(-4)). We also identified variants at ADCY5 (rs2877716, P = 4.2 x 10(-16)), VPS13C (rs17271305, P = 4.1 x 10(-8)), GCKR (rs1260326, P = 7.1 x 10(-11)) and TCF7L2 (rs7903146, P = 4.2 x 10(-10)) associated with 2-h glucose. Of the three newly implicated loci (GIPR, ADCY5 and VPS13C), only ADCY5 was found to be associated with type 2 diabetes in collaborating studies (n = 35,869 cases, 89,798 controls, OR = 1.12, 95% CI 1.09-1.15, P = 4.8 x 10(-18)).

Citing Articles

Associations Between TCF7L2, PPARγ, and KCNJ11 Genotypes and Insulin Response to an Oral Glucose Tolerance Test: A Systematic Review.

Blanken C, Bayer S, Buchner Carro S, Hauner H, Holzapfel C Mol Nutr Food Res. 2025; 69(3):e202400561.

PMID: 39828593 PMC: 11791742. DOI: 10.1002/mnfr.202400561.

Genetic Variant Analyses Identify Novel Candidate Autism Risk Genes from a Highly Consanguineous Cohort of 104 Families from Oman.

Gupta V, Ben-Mahmoud A, Idris A, Hottenga J, Habbab W, Alsayegh A Int J Mol Sci. 2025; 25(24.

PMID: 39769462 PMC: 11679916. DOI: 10.3390/ijms252413700.

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354.

Rees T, Buttle B, Tasma Z, Yang S, Harris P, Walker C Front Pharmacol. 2024; 15:1463313.

PMID: 39464637 PMC: 11502443. DOI: 10.3389/fphar.2024.1463313.

Understanding the Genetic Landscape of Gestational Diabetes: Insights into the Causes and Consequences of Elevated Glucose Levels in Pregnancy.

Brito Nunes C, Borges M, Freathy R, Lawlor D, Qvigstad E, Evans D Metabolites. 2024; 14(9).

PMID: 39330515 PMC: 11434570. DOI: 10.3390/metabo14090508.

Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide.

Taktaz F, Fontanella R, Scisciola L, Pesapane A, Basilicata M, Ghosh P Cardiovasc Diabetol. 2024; 23(1):242.

PMID: 38987789 PMC: 11238498. DOI: 10.1186/s12933-024-02319-7.

References

Chen W, Erdos M, Jackson A, Saxena R, Sanna S, Silver K . Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest. 2008; 118(7):2620-8. PMC: 2398737. DOI: 10.1172/JCI34566. View

Schousboe K, Visscher P, Henriksen J, Hopper J, Sorensen T, Kyvik K . Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia. 2003; 46(9):1276-83. DOI: 10.1007/s00125-003-1165-x. View

Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y . Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999; 96(26):14843-7. PMC: 24735. DOI: 10.1073/pnas.96.26.14843. View

Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D . Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004; 164(19):2090-5. DOI: 10.1001/archinte.164.19.2090. View

Leech C, Castonguay M, Habener J . Expression of adenylyl cyclase subtypes in pancreatic beta-cells. Biochem Biophys Res Commun. 1999; 254(3):703-6. DOI: 10.1006/bbrc.1998.9906. View

Qiao Q, Tuomilehto J, Borch-Johnsen K . Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia. 2003; 46 Suppl 1:M17-21. DOI: 10.1007/s00125-002-0932-4. View

Nauck M, Homberger E, Siegel E, Allen R, EATON R, Ebert R . Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab. 1986; 63(2):492-8. DOI: 10.1210/jcem-63-2-492. View

Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, Cavalcanti-Proenca C . A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science. 2008; 320(5879):1085-8. DOI: 10.1126/science.1156849. View

Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C . Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes. 2008; 57(11):3112-21. PMC: 2570409. DOI: 10.2337/db08-0516. View

10.

Prokopenko I, McCarthy M, Lindgren C . Type 2 diabetes: new genes, new understanding. Trends Genet. 2008; 24(12):613-21. PMC: 7116807. DOI: 10.1016/j.tig.2008.09.004. View

11.

Holst J, Gromada J, Nauck M . The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia. 1997; 40(8):984-6. DOI: 10.1007/s001250050779. View

12.

Nitz I, Fisher E, Weikert C, Burwinkel B, Li Y, Mohlig M . Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol Nutr Food Res. 2007; 51(8):1046-52. DOI: 10.1002/mnfr.200700048. View

13.

Prokopenko I, Langenberg C, Florez J, Saxena R, Soranzo N, Thorleifsson G . Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2008; 41(1):77-81. PMC: 2682768. DOI: 10.1038/ng.290. View

14.

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson A . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42(2):105-16. PMC: 3018764. DOI: 10.1038/ng.520. View

15.

Ahren B, Pacini G . Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol. 2004; 150(2):97-104. DOI: 10.1530/eje.0.1500097. View

16.

Meigs J, Nathan D, DAgostino Sr R, Wilson P . Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002; 25(10):1845-50. DOI: 10.2337/diacare.25.10.1845. View

17.

Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P . Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007; 117(8):2155-63. PMC: 1934596. DOI: 10.1172/JCI30706. View

18.

Velayos-Baeza A, Vettori A, Copley R, Dobson-Stone C, Monaco A . Analysis of the human VPS13 gene family. Genomics. 2004; 84(3):536-49. DOI: 10.1016/j.ygeno.2004.04.012. View

19.

Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M . A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2008; 41(1):89-94. DOI: 10.1038/ng.277. View

20.

Drucker D . The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117(1):24-32. PMC: 1716213. DOI: 10.1172/JCI30076. View